Trial intelligence / Profile preview

TPF induction and CCRT in young NPC patients

NCT03020329Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Nov 2016
Primary completion
Dec 2020
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 2 trial of liposomal paclitaxel, cisplatin, fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

liposomal paclitaxelcisplatinfluorouracil
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT03020329.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03020329.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call